Biological basis of late life depression.

Current Psychiatry Reports
Brianne M Disabato, Yvette I Sheline

Abstract

Late life depression (LLD) is an important area of research given the growing elderly population. The purpose of this review is to examine the available evidence for the biological basis of LLD. Structural neuroimaging shows specific gray matter structural changes in LLD as well as ischemic lesion burden via white matter hyperintensities. Similarly, specific neuropsychological deficits have been found in LLD. An inflammatory response is another possible underlying contributor to the pathophysiology of LLD. We review the available literature examining these multiple facets of LLD and how each may affect clinical outcome in the depressed elderly.

References

May 1, 1992·The American Journal of Psychiatry·F W BrownS C Risch
Oct 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·R P Hart, J A Kwentus
Jan 1, 1993·Archives of General Psychiatry·C E CoffeyC E Spritzer
Sep 1, 1996·The American Journal of Psychiatry·B S GreenwaldM Patel
Apr 1, 1997·The American Journal of Psychiatry·K R KrishnanD G Blazer
Mar 1, 1997·The Journal of Pathology·H Moshage
Oct 24, 1997·Archives of General Psychiatry·G S AlexopoulosM Charlson
Jan 1, 1999·Depression and Anxiety·K R KrishnanD G Blazer
Jan 27, 1999·Journal of the American Geriatrics Society·A N DentinoH J Cohen
Aug 6, 1999·Archives of General Psychiatry·B Kalayam, G S Alexopoulos
Apr 28, 2000·The American Journal of Psychiatry·Z Kronfol, D G Remick
Aug 26, 2000·Biological Psychiatry·D C SteffensK R Krishnan
Dec 1, 2000·The American Journal of Psychiatry·M A ButtersC F Reynolds
Jun 16, 2001·Psychiatry Research·R D NebesC F Reynolds
Sep 18, 2001·Journal of the American Geriatrics Society·B S GreenwaldS Pollack
Sep 22, 2001·Brain, Behavior, and Immunity·E P ZorrillaK Schmidt
Jan 30, 2002·Depression and Anxiety·David C SteffensJames R MacFall
Jul 12, 2002·International Journal of Geriatric Psychiatry·Ming-Hong HsiehDavid C Steffens
Aug 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Alan J ThomasJohn T O'Brien
Aug 3, 2002·The American Journal of Psychiatry·Sandra Bell-McGintyJames T Becker
Nov 2, 2002·The American Journal of Psychiatry·George S AlexopoulosKelvin O Lim
Dec 25, 2002·Epidemiology·Henning TiemeierMonique M B Breteler
Aug 30, 2003·Biological Psychiatry·Shwu-Hua LeeK Ranga Rama Krishnan
Nov 12, 2003·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Robert M LevyK Ranga Rama Krishnan
Nov 12, 2003·Archives of General Psychiatry·Warren D TaylorK Ranga Rama Krishnan
Mar 25, 2004·European Heart Journal·Demosthenes B PanagiotakosUNKNOWN ATTICA study
Apr 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Victor NavarroTeodoro Marcos
May 8, 2004·Experimental Gerontology·Karen Suárez KrabbeHelle Bruunsgaard
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Adrian J LloydJohn T O'Brien
Jun 9, 2004·Archives of General Psychiatry·Meryl A ButtersJames T Becker
Jun 26, 2004·Stroke; a Journal of Cerebral Circulation·Tom JeerakathilCharles DeCarli
Oct 30, 2004·The American Journal of Psychiatry·John T O'BrienNicol Ferrier

❮ Previous
Next ❯

Citations

Jan 29, 2013·Journal of Neural Transmission·Kurt A Jellinger
Apr 26, 2014·PloS One·Reza TadayonnejadOlusola Ajilore
Jun 3, 2014·Journal of Affective Disorders·Fabienne CyprienSylvaine Artero
May 7, 2013·Expert Opinion on Drug Metabolism & Toxicology·Pothitos M PitychoutisZeta Papadopoulou-Daifoti
Jun 25, 2014·Schizophrenia Research·Kelly Rowe BijankiNancy C Andreasen
Oct 1, 2015·Journal of Neural Transmission·Ivo MarxStefan Cohrs
Feb 18, 2015·International Journal of Geriatric Psychiatry·Meenal J PatelHoward J Aizenstein
Nov 12, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Joshua W KirtonVonetta M Dotson
Apr 20, 2016·Translational Psychiatry·M E McLarenV M Dotson
Apr 1, 2015·PloS One·Kathrin ReetzNadim Jon Shah
Nov 4, 2016·BMC Medicine·Howard J AizensteinOren Tene
Dec 6, 2016·International Journal of Molecular Sciences·Mónica Martínez-CengotitabengoaAna González-Pinto
Jan 2, 2014·Journal of Geriatric Psychiatry and Neurology·Reza Tadayonnejad, Olusola Ajilore
Apr 17, 2018·Journal of the American Geriatrics Society·Kathy D Wright
Apr 18, 2013·Behavioural Pharmacology·Miao-Kun Sun, Daniel L Alkon
Sep 9, 2018·Journal of Psychiatric Research·Apoorva BhandariDaniel M Blumberger
Jan 1, 2017·Psychiatry Research. Neuroimaging·Molly E McLarenVonetta M Dotson
Mar 13, 2019·Dementia and Geriatric Cognitive Disorders·Leigh Ann JohnsonSid E O'Bryant

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.